Procoagulant protein levels are differentially increased during human endotoxemia

被引:48
作者
Reitsma, PH
Branger, J
Van den Blink, B
Weijer, S
Van Der Poll, T
Meijers, JCM
机构
[1] Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
coagulation proteins; inflammation; risk factors; venous thrombosis;
D O I
10.1046/j.1538-7836.2003.00237.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
On the basis of plasma interleukin levels it was suggested that there is an inflammatory component to the risk of venous thrombotic disease. Other evidence shows that elevated levels of coagulation factor (F)VIII, FIX, FX and FXI are risk indicators for venous thrombosis, but the reasons for elevation remain unclear. We tested the hypothesis that the elevated levels could reflect an inflammatory reaction by measuring coagulation factor levels during experimental human endotoxemia. Male volunteers received endotoxin (4 ng kg(-1)), and blood samples were obtained before and at multiple time points after the challenge. Plasma was used for a panel of coagulation tests. Antigen levels of FVIII, von Willebrand factor (VWF), FIX, and FX were increased after endotoxin administration, reaching peak levels between 2 and 5 h. Within 24 h levels normalized, except for FVIII and VWF levels that remained at >200%. Fibrinogen levels, and to a lesser extent FXI levels, also responded with an increase, but slower. These levels did not return to normal during the observation period. FVII levels were strongly depressed. FVIII, FIX and FX reacted immediately and strongly to endotoxin administration. The time pattern of this response is different from the slower so-called acute phase response, which appeared to be followed by FXI and fibrinogen. These increased levels of coagulation factors during an inflammatory state provide new ways of explaining why elevated levels of FVIII, FIX and FXI behave as risk indicators disease.
引用
收藏
页码:1019 / 1023
页数:5
相关论文
共 19 条
[1]   Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia [J].
de Jonge, E ;
Dekkers, PEP ;
Creasey, AA ;
Hack, CE ;
Paulson, SK ;
Karim, A ;
Kesecioglu, J ;
Levi, M ;
van Deventer, SJH ;
van der Poll, T .
BLOOD, 2000, 95 (04) :1124-1129
[2]   Genetic risk factors of venous thrombosis [J].
Franco, RF ;
Reitsma, PH .
HUMAN GENETICS, 2001, 109 (04) :369-384
[3]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[4]  
GRALNICK HR, 1989, J LAB CLIN MED, V113, P118
[5]   Tissue distribution of factor VIII gene expression in vivo -: A closer look [J].
Hollestelle, MJ ;
Thinnes, T ;
Crain, K ;
Stiko, A ;
Kruijt, JK ;
van Berkel, TJC ;
Loskutoff, DJ ;
van Mourik, JA .
THROMBOSIS AND HAEMOSTASIS, 2001, 86 (03) :855-861
[6]   High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene [J].
Kamphuisen, PW ;
Eikenboom, JCJ ;
Rosendaal, FR ;
Koster, T ;
Blann, AD ;
Vos, HL ;
Bertina, RM .
BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (01) :156-158
[7]   Acute phase response in familial Mediterranean fever [J].
Korkmaz, C ;
Özdogan, H ;
Kasapçopur, Ö ;
Yazici, H .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (01) :79-81
[8]   ROLE OF CLOTTING FACTOR-VIII IN EFFECT OF VON-WILLEBRAND-FACTOR ON OCCURRENCE OF DEEP-VEIN THROMBOSIS [J].
KOSTER, T ;
BLANN, AD ;
BRIET, E ;
VANDENBROUCKE, JP ;
ROSENDAAL, FR .
LANCET, 1995, 345 (8943) :152-155
[9]  
Mansvelt EPG, 1998, THROMB HAEMOSTASIS, V80, P561
[10]   High levels of coagulation factor XI as a risk factor for venous thrombosis. [J].
Meijers, JCM ;
Tekelenburg, WLH ;
Bouma, BN ;
Bertina, RM ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (10) :696-701